Pfizer, BioNTech start trial on one vaccine to prevent both Covid-19, influenza
HQ Team November 4, 2022: The US-based drugmaker Pfizer Inc and Germany’s BioNTech have started clinical trials for a vaccine to prevent both.
Drugs
Pharma
Drugs
Medical
Cholera vaccine shortage forces one-dose strategy: WHO
Shortage of cholera vaccines forces global agencies to shift to single doses instead of recommended two
Drugs
Pharma
Merck pays Moderna $250m for joint development of skin cancer vaccine
Moderna’s mRNA vaccine is being studied in combination with Merck’s Keytruda to treat patients with high-risk melanoma